Neurology

Article	Citations
Reduced Time to Treatment After Implementation of a Standardized Guideline for the Diagnostic Evaluation and Acute Management of Suspected Autoimmune Encephalitis in Hospitalized Adult Patients (P9-8.	354
Teaching NeuroImage: Foramen Magnum Dural Arteriovenous Fistula Presenting With Thoracolumbar Myelopathy	342
Spinal Cord Infarction Associated with Patent Formale Ovale and Venous Thromboembolism: A Case Report (P8-13.005)	218
Standardized Inpatient Telestroke to Improve Access to Stroke Specialists (P12-14.015)	192
Improving Median Overall Survival (OS) of Glioblastoma (GBM) Patients by Optimizing Standard of Care (SOC) Through Multidisciplinary Team Work and Combination Therapies Including Tumor Treating Fields	157
Frailty increases the risk of Alzheimer’s disease in non-demented individuals: a longitudinal cohort study (P6-3.008)	151
Role of the UNC13 Family in Human Diseases: A Literature Review (P9-2.003)	147
Predicting Cognitive Decline Using Baseline Data in Cognitively Unimpaired Older Adults: Results from the A4 Trial (P2-3.018)	139
Rational Design of a Vaccine for Synucleinopathies Using Computationally-Derived Conformational B Cell Epitopes To Selectively Target Pathogenic Alpha-Synuclein Species (P8-3.007)	132
Traumatic Brain Injury and Depressive Symptoms in Community Dwelling Older Adults (P3-4.007)	127
Lifestyle Contributors to Frequent Headaches in Youth	122
Exploring Clinical Outcomes of ABCDEF Bundle Implementation in Neurocritical Patients: Insights from Two Years of ICU Humanization (P9-7.006)	116
Analysis of the Efficacy of Efgartigimod in a Refractory OMG Patient (P1-11.019)	114
Frequency and Severity of Neurological Symptoms Following Gluten Exposure in Individuals with Celiac Disease (P1-2.010)	112
Impact of Psychiatric Conditions on the Real-world Effectiveness of Eptinezumab Treatment in Patients with Chronic Migraine (P4-12.005)	111
Peripheral Neuropathy	108
Teaching Video NeuroImage: Pattern-Induced Seizures Without Photosensitivity in Glutaric Aciduria	107
Resting-state Regional Cerebral Blood Flow Alterations in Macrovasculature and Microvasculature in Parkinson’s Disease: A Systematic Review and Meta-analysis (P3-5.013)	106
Development and Validation of a Nomogram Prediction Model for New Stroke in Community Population (P10-13.004)	106
Exploring Racial Disparities in Advanced Care Planning Documentation for Stroke Patients (P10-13.020)	99
Rethinking Thunderclap Headaches: A Critical Look at Cerebral Venous Sinus Thrombosis (P3-13.020)	99
Automated Data Extraction Using Large Language Models in Vascular and Interventional Neurology Research: Towards an AI Fully Assistant Automated Research (P9-14.007)	98
Effectiveness of Ataluren in Patients with nmDMD: Confirmatory Evidence from the STRIDE Registry (P7-6.008)	96
Brain Perfusion Imaging and Cardiac Thrombus Detection	95
Demographic and Regional Trends of Meningitis-related Mortality in the United States from 1999 to 2020: a CDC WONDER Analysis (P3-10.004)	94

Modifiable Vascular Risk Factors and Subsequent Brain Metrics in Hispanic/Latino Populations	93
IgG4-Related Hypertrophic Pachymeningitis Mimicking Neuromyelitis Optica: a Case Report (P10-8.004)	93
Capturing Patient and Caregiver Perspectives on Parkinson’s Disease in Zambia: A Methodology (P6-11.014)	93
Patient Education and Unmet Needs: Pregnancy and Postpartum Counseling in MS (P6-1.014)	90
Clinical and Genetic Profiles of Congenital Myasthenic Syndromes: A Single Tertiary Care Center Experience from Saudi Arabia (P12-11.029)	90
Evaluating Brain Health in Women	88
Elevated Pre-hospital Blood Pressure is Associated with Reduced Infarct Volume in Large Vessel Occlusion Ischemic Strokes (P12-13.016)	88
Wobbling Through the Spectrum: Anti-GQ1b Antibody Syndrome Presenting with Generalized Myoclonus and Ataxia (P4-8.018)	87
A Novel IONM Protocol for Distal Femoral Extension Osteotomies (P6-6.010)	87
Teaching Video NeuroImage: Reflex Epilepsy—Seizures Triggered by a Geometric Pattern	87
Case Report of a Unique Structural Cause for Rapidly Progressive Orthostatic Syncope (P7-2.001)	86
Overdiagnosis of Autism Spectrum Disorder: Diagnostic and Management Challenges in a Pediatric Outpatient Clinic (P6-6.003)	85
Outcomes of a Three Week Interdisciplinary Intensive Outpatient Treatment Program for Mild-Moderate Traumatic Brain Injury in Veterans and First Responders (P7-4.006)	85
Hereditary Transthyretin Amyloidosis at Geisinger Medical Center: A Four-year Multidisciplinary Clinic Experience (P6-11.033)	84
Having Second Thoughts About Parkinson Diagnosis	84
Distinguishing Features of MOG Positive and MOG Negative Pediatric Patients with ADEM (S2.008)	83
NETSseq Identifies Novel Therapeutic Targets for Neurodegenerative Diseases (P3-3.008)	82
Consent Deviations in an Acute Ischemic Stroke Clinical Trial (P5-13.017)	81
Effect Sizes of Once-daily Valbenazine for Chorea Associated with Huntington’s Disease: A Post-hoc Analysis of KINECT®-HD Data (P10-5.012)	81
Pediatric SMART Syndrome in a 10-year-old boy: A Case-Report (P5-6.005)	80
Spontaneous Closure Of A Dural Arteriovenous Fistula: A Case Report (P5-14.011)	79
Severity of Hearing Loss as a Predictor of Dementia Risk: Insights from the ARIC Study (P9-3.013)	78
Localizing Lesions in the Peripheral Nervous System using Generative Artificial Intelligence (P1-2.009)	78
The Midbrain Paradox: Bilateral Vertical Gaze Palsy from a Single Sided Lesion (P2-11.007)	77
Inter-Institutional Collaborative Opportunity For Medical Students in the Neurosciences: Annual Student Interest Group in Neurology (SIGN) Forum (P5-5.021)	76
Radiological Signs in Spinal Cord Infarct (SCI) and Association with Anatomic Location. (P9-13.005)	76
Multimodal Regression Based Assessment of Longitudinal Evolution Trends in Inflammatory Myositis (IIM) (P3-11.018)	75
Teaching Neuro Images : CNS actinomycosis in an immunocompetent patient	75
My First Patient With Alzheimer's	74
Reader Response: Teaching NeuroImage: Cryptococcal Meningoencephalitis With Cryptococcoma and Gelatinous Pseudocysts	74
Comparative Efficacy of Adjuvant Rifampicin, Levofloxacin, and Their Combination in Tuberculous Meningitis With and Without HIV Co-infection: A Systematic Review and Meta-Analysis	73
Incidence of Relapses After Meningococcal Vaccination in Clinical Trials of Eculizumab and Ravulizumab in Anti-Aquaporin-4 Antibody-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)	73
Neuropsychologic Impact of MOGAD: A Patient Reported Outcomes Study	73
Measles, Rubella, and Varicella-Zoster Viral Antibodies and Clinical Prognosis After 20 Years in Persons with Multiple Sclerosis	73
Coexistance of Probable Neurosarcoidosis and Generalized Myasthenia Gravis: Case Report	72
Assessing the Impact of Immune Checkpoint Inhibitor Therapy on Disease Activity in Multiple Sclerosis Patients	72
Author Response: D313Y Variant in Fabry Disease: A Systematic Review and Meta-analysis	71
Glial Fibrillary Acidic Protein (GFAP) Antibody-Associated Astrocytopathy in Systemic Sarcoidosis	71
NMDA Receptor Encephalitis With Severe Orofacial Dyskinesias Treated With Tramadol and Clonazepam	71
Racial and Socioeconomic Disparities in Ischemic Stroke Outcomes among Non-lytic/Thrombectomy Patients (P7-5.008)	70
A Broader Perspective on Motor Rehabilitation Guidelines for Cerebral Palsy	70
Lysine Reduction and Cognitive Outcomes in Pyridoxine-Dependent Epilepsy	69
Performance Assessment of the New EUROLINE Neurologic Syndrome 15 Ag (IgG) for the Determination of Autoantibodies Associated with Neurological Disorders	69
Assessing Social Cognition Across Dementia Subtypes (P6-6.004)	67
Autoimmune Cerebellar Ataxia Associated with TNF-Alpha Blocking Therapy in a Patient with Rheumatoid Arthritis: A Case Report and Literature Review (P8-8.003)	67
Nitrous Oxide-Induced Vitamin B12 Deficiency and Myelopathy: A Report of Two Cases (P11-2.006)	67
Jugular Variant Bow-Hunter’s Syndrome from Sternocleidomastoid Entrapment of the Internal Jugular Vein (P11-10.001)	67
Group D Salmonella Meningitis in the Neonate (P5-6.010)	67
Improving Residents’ Knowledge and Interest in Outpatient Neurology through an Interactive, Discussion-Based, Patient-Centered Didactic Series (P2-2.006)	66
Data-Driven Genome-Wide Association Study of Pain Trajectories in Persons with Parkinson’s Disease (P7-11.012)	66

Dystonia with myoclonus and vertical supranuclear gaze palsy associated with a rare GNB1 variant (P11-11.008)	66
Neurocognitive Manifestations of Individuals with NF1 Microdeletions (P14-9.007)	66
Analysis of the Epidemiologic Profile, Prevalence, and Incidence of Migraine out of 15,490 Spontaneous Intracranial Hypotension Patients from a Multicenter Record Database (TriNetX) (P2-12.008)	65
Serum Glucose Fluctuations Is an Independent Predictor of Adverse Outcomes in Patients with Acute Ischemic Stroke Undergoing Endovascular Treatment (P7-5.014)	65
Preclinical Development of a T Cell Receptor-engineered Regulatory T Cell Therapy for Progressive MS (S17.004)	63
African-Americans With Multiple Sclerosis Have a Higher Proportion of B-Cell Lineage Cells in Their Cerebrospinal Fluid (CSF) Than White Patients (P9-3.010)	63
Survival and Clinical Characteristics of Patients with Glioblastoma with Primitive Neuronal Component (P13-13.004)	61
Machine-learning Assisted Swallowing Assessment: A Deep Learning-based Quality Improvement Tool to Screen for Post-stroke Dysphagia (S6.004)	61
Assessing Undergraduate Neurology Pipeline Programs: A Systematic Review (P11-2.001)	61
MOG antibody-associated encephalitis in adult: clinical phenotypes and outcomes (P13-5.020)	61
Levamisole-associated Toxic Multifocal Inflammatory Leukoencephalopathy: A Case Report (P7-3.006)	60
Evaluating Quality of Website-Derived Concussion Information (P8-1.005)	60
Identification of a Novel NOTCH3 Mutation in a Case of CADASIL Initially Diagnosed as Demyelinating Disease (P3-3.010)	60
Patterns of Benzodiazepine Initiation Among Older Acute Ischemic Stroke Survivors (P1-10.006)	60
Gadolinium Enhancement Patterns in Leptomeningeal Disease (P2-2.001)	60
Tenecteplase Is a Better Alternative to Alteplase for Patients With Large Vessel Occlusion Stroke Receiving Bridging Therapy	59
Efficacy and Safety of Anti-CGRP Monoclonal Antibodies for Migraine Preventative Treatment (P6-12.011)	59
A Gender Affirming Experience; The RNS System Tracking Seizure Frequency During Gender Changing Hormonal Therapy (P5-9.006)	59
Pathologically- confirmed Osmotic Demyelination in the Case of Clinically and Radiographically Progressive Encephalopathy due to Liver Disease and Malnutrition. (P4-4.007)	59
Development of eIF2B Activator ABBV-CLS-7262 as a Novel Treatment for Vanishing White Matter Disease (P2-8.001)	58
Metronidazole Induced Encephalopathy Responsive to High Dose Thiamine (P4-12.006)	58
COVID-19 Disrupts Sleep Architecture by Reducing N3 Stage Sleep (S25.010)	58
Tuberculous Meningitis: Is the Fixed Dose Anti-TB treatment strategy effective? Case report from Sri Lanka (P3-10.002)	58
‘Code Brain’- Mannequin Based Simulation Exercise to Enhance Identification, Evaluation, and Management of Cerebral Herniation for Neurology Residents. (P5-5.027)	57
Association of Subthalamic Beta Frequency Sub-bands to Symptom Severity in Patients with Parkinson’s Disease: A Systematic Review (P5-11.014)	57
Designing Transgene Vectors for ALS Therapeutics (P11-4.010)	57
Recognizing Neuropathic Pain as a Symptom of Charcot-Marie-Tooth Disease that impacts Quality of Life (P14-8.005)	57
Ixekizumab-associated transverse myelopathy in a patient with psoriatic arthritis (P14-3.017)	57
Safety and Efficacy of Inebilizumab in AQP4+ NMOSD Participants with History of Immunosuppression Treatment Prior to N-MOmentum Study (P13-5.003)	57
4 mA tDCS improves walking ability in PSP: A case study (P9-11.012)	57
Reconsidering the Ethics of Provocation Techniques for Psychogenic Non-epileptic Seizures and Proposed Ethical Guidelines for Use (P2-10.005)	57
What’s that Mass? A Sphenoid Lesion Causing Cavernous Sinus Syndrome (P3-14.009)	56
Computational Models of Age-associated Cognitive Slowing and Memory Loss (P6-9.010)	56
Role of 18F-Florzolotau PET in Diagnostic and Therapeutic Decision-Making for Cognitive Impairment (N4.001)	55
Pearls & Oy-sters: Severe Myotonic Crisis Resembling Malignant Hyperthermia	55
A Ten-year Delayed Diagnosis of Hereditary Spastic Paraplegia Type-10: Key Clinical, Electrodiagnostic, and Genetic Findings (P11-11.004)	55
A pioneer in the History of Women in Neurology - Historical Review of the Life and Contributions of Augusta Déjerine-Klumpke (P4-11.009)	55
Multimodal Approach to NMOSD Relapse Treatment: Experience with Two Cases (P10-8.011)	55
Endovascular Therapy for NIHSS ≤5	55
Role of Pre-operative Mild Cognitive Impairment in Patients Undergoing Deep Brain Stimulation for Parkinson’s Disease: Systematic Review (P2-3.011)	54
Personalized Alzheimer’s Risk Reduction Software Improves Calculated Alzheimer’s Risk: A Digital, Decentralized, Randomized Controlled Trial (P1-3.004)	54
Neuroimaging Evidence of Cortical-subcortical Network Involvement in Patients with Cortical Lateralized Periodic Discharges (P5-1.004)	54
Serum Neuroinflammatory Biomarkers and Long-term Cognitive Dysfunction (P11-13.002)	54
The Safety and Efficacy of Chronic Weekly Rozanolixizumab Treatment in Patients with Generalized Myasthenia Gravis (MG0004) (P4-14.017)	54
7T MRI Leptomeningeal Enhancement and Brain Atrophy Are Associated with Alterations in Arginine-polyamine Metabolism in Multiple Sclerosis (P11-6.007)	53
The Path to Finding a Unifying Diagnosis – A Case Report of Mitchell Syndrome in a Pediatric Patient (P2-8.005)	53
Drug-Resistant GAD65-Associated Epilepsy: Pre-Surgical Evaluation and Comparison to Temporal Lobe Epilepsy of Other Etiology (P2-9.005)	52
The iNPH Radscale May Better Predict Whether Ventriculoperitonal Shunting was Offered, Compared to Drain Trial Gait Variables (P1-5.022)	52
Focal Cerebral CNS Vasculitis due to SARS-CoV-2 Infection (P4-10.007)	52
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) and Anti-N-Methyl-D-Aspartate Receptor Encephalitis (NMDARE) Overlapping Syndrome Presenting as Tics and Cognitive Symptoms (P10	52
Perceived Stress and its Association with Sleep Quality in Patients with Neuropathic Pain and Distal Symmetric Polyneuropathy (P3-11.020)	51
Opicapone as First-line Strategy for the Treatment of Wearing-off in Patients with Parkinson’s Disease (P7-5.026)	51
Characteristics of Adult Essential Tremor Patients Seeking Participation in a Decentralized US Clinical Trial: Pre-screener Findings from the Essential3 Program Evaluating Efficacy and Safety of Ulixa	51
Racial Disparities in Mental Health Among Stroke Survivors in the REDUCE Study (P1-13.014)	51
Pregnancy-related Anticipatory Guidance for People with Epilepsy in Pediatric and Adult Neurology (P1-9.015)	51
Impact of an Inpatient Stroke Education Program on Stroke Knowledge in Lusaka, Zambia (S24.005)	50
Socioeconomic Disparities in Aspiration Pneumonia Hospitalizations in Parkinson’s Disease Patients (P2-5.006)	50
Unveiling the Diagnostic and Therapeutic Challenges: A Singular Case of Syphilitic Myelitis in an HIV-Positive Patient (P5-10.007)	50
Cognitive sequelae in MOG antibody-associated disease (P13-5.025)	49
A Fatal Case of CNS Actinomyces Mimicking Tolosa-Hunt Syndrome: Is it Time to Reevaluate Diagnostic Criteria? (P10-10.004)	49
Teaching NeuroImage: Wallerian Degeneration of the Corticospinal Tract After Cerebral Hemorrhage	49
Blood Pressure Variability as a Marker of Sympathetic Hyperreactivity in Postpartum Patients with Preeclampsia, with and without Chronic Hypertension (P2-7.003)	49
Physiological β-Amyloid Clearance by the Liver and Its Therapeutic Potential for Alzheimer’s Disease (P12-3.010)	49
Prospective Long-term Seizure Outcomes in Medically-resistant Focal Epilepsy Subjects with Neuromodulation Devices (P3-1.009)	49
Cortical Microglial Activation on [F-18]PBR06-PET Predicts Progression Independent of Relapse Activity (PIRA) in Multiple Sclerosis: A 4.5-year Longitudinal Study (S33.006)	48
Benign Paroxysmal Positional Vertigo: The “SemontPLUS Maneuver” is more effective than the Epley Maneuver – a Prospective Tri-national Randomized Single-Blinded Trial in 195 Patients (S12.003)	48
Collateral Score and Clot Burden Score in the Era of Tenecteplase (P3-13.007)	48
Expanding the Clinical Spectrum of NUBPL Associated Disorders: Previously Unidentified NUBPL Variants Uncovered by Genome Sequencing in Sibling Pair (P10-6.009)	47
Detecting Smouldering Multiple Sclerosis with Real-world Mobility Monitoring (P2-1.001)	47
Deep Brain Stimulation (DBS) in Pediatric Dystonia: The Youngest Case of Neuromodulation for Refractory Acquired Dystonia and Status Dystonicus with 1-year Follow-up (P10-5.008)	47
Correlation of Headache Frequency and Intensity with the Risk of Obstructive Sleep Apnea in Patients with Idiopathic Intracranial Hypertension (P10-12.007)	46
Contributions of Traumatic Brain Injury and Repetitive Head Impacts to Chronic Deficits in Recognition Memory in Military Veterans (P2-3.020)	46
Neurocognitive Function and Psychiatric Comorbidities in Patients with Epilepsy with Eyelid Myoclonia (P7-9.002)	46
Amelogenesis Imperfecta and Epilepsy	46
The Grand Masquerade of a Rare Neurological Illness: A Case Report of Anti-IgLON5 Antibody Disease (P3-8.008)	46
Effgartigimod Helps Avert Post-Thymectomy Crises in Patients with Myasthenia Gravis Classified as MGFA IIIb or Higher (P7-11.026)	45
Healthcare Resource Utilization in Patients with Stiff-Person Spectrum Disorder (P2-8.003)	45
Diffuse Leptomeningeal Glioneuronal Tumor (DLGNT) with Direct Cystic Infiltration of the Optic Chiasm and Tracts (P1-9.003)	45
Twenty-Year Disparity Trends in U.S. Sleep Disorder Mortality by Age, Race/Ethnicity, Geography, and Socioeconomic Status. (P8-11.020)	45
Brain White Matter Microstructural Alterations in Behcet’s Syndrome Correlate with Cognitive Impairment and Disease Severity: A Diffusion Tensor Imaging Study (P3-1.002)	45

The Role of Platelet Rich Plasma in the Management of Vertebrogenic and Discogenic Pain (P5-13.004)	44
Clinical and Autonomic Features Suggest Phenoconversion from Sporadic Adult-onset Ataxia to Clinically Probable Multiple System Atrophy (P6-3.019)	44
Mechanical Angioplasty with Comaneci for the Treatment Refractory Vasospasm Secondary to Coccidioidal Meningits (P2-7.005)	44
Analyzing White Matter Integrity of the Basolateral Amygdala and Subgenual Anterior Cingulate Cortex and Its Association with Depression in Adults with Autism Spectrum Disorder Using the Shannon Entro	44
Measuring Synaptic Density and Dopamine Transporter Availability in Parkinson's Disease: A PET Imaging Study with 11C-UCB-J and 18F-FE-PE2I (P7-3.007)	44
ICU Management of Severe Myotonic Crisis in the Setting of Beta-Adrenergic Agonist Use: A Case Report (P10-11.012)	44
Incorporating Patient Perspectives into a Composite Score for Measuring Disease Progression in Spinocerebellar Ataxia (SCA) (P12-5.028)	44
Risk Factors and Outcome of Cerebrovascular Complications in Transplant Recipients (P14-5.013)	44
Quantitative Retinal Vascular Features as Biomarkers for CADASIL: A Case-Control Study from the UK Biobank (P9-13.003)	44
Facing the challenges of chief resident year: A standardized experiential simulation leadership curriculum (S13.002)	43
Amyotrophic Lateral Sclerosis Survival and Occupational Lead Exposure in the Danish National Patient Registry (P2-15.002)	43
Withdrawing Antiseizure Medications in Seizure-Free Patients: The Role of 24-Hour Video EEG (P4-9.013)	43
Teaching NeuroImage: Prognostication of X-Linked Adrenoleukodystrophy Based on the Loes Neuroimaging Score	43
Relationships among Hospital Acute Ischemic Stroke Volumes, Hospital Characteristics, and Outcomes in the US (P14-5.025)	43
Editors' Note: Patient Travel Distance to Neurologist Visits	43
Examining Age-Specific Barriers and Facilitators to Research Participation in Underrepresented Americans (P14-6.003)	43
Paws for Relief	42
A Preliminary Systematic Review and Meta-analysis of Randomized Control Trials of Rimegepant and Zavegepant for Acute Pain Relief from Migraine (P9-12.004)	42
2024 Annual Highlights of the Resident & Fellow Section: A Representative Collection of Previously Published Articles	42
Author Response: Pediatric and Adult Brain Death/Death by Neurologic Criteria Consensus Guideline: Report of the AAN Guidelines Subcommittee, AAP, CNS, and SCCM	42
Methylation Patterns Differ Between ICH Cases and Controls (S34.002)	42
Unraveling Complexity: Concurrent Myxopapillary Ependymoma and Pancreatic Gastrinoma in a Young Adult - A Syndromic Association or Mere Coincidence? (P6-5.010)	42
Deep Phenotyping of Executive Function Deficits Using the NIH Toolbox in Duchenne Muscular Dystrophy (P1-11.014)	42
Use of a Trial Innovation Network (TIN) Recruitment Innovation Center (RIC) Survey to Improve Subject Recruitment and Enrollment in an Adolescent Concussion Study: CARE4Kids (P2-14.004)	42
Community-driven Brain Health Workshop Series: A Novel Approach to Brain Health Promotion in Rochester’s Historically Marginalized Communities (P1-4.007)	42
A Novel Variant of NBEA Causing Paroxysmal Kinesogenic Dyskinesia (P8-5.019)	42
The Risk of Depression in a Large Huntington Disease Population Compared With Controls: Analysis of the Enroll-HD Registry Data (P1-11.012)	42
CTA Collaterals, HIR, and Infarct Volume: Which Imaging Modality Best Predicts Clinical Outcomes in Acute Ischemic Stroke Endovascular Treatment? (S2.010)	42
COVID-19 Infection Presents as Acute Cerebellar Ataxia (P6-10.003)	42
Determining the Impact of Longitudinal Simulation-based Learning and Evaluation on Neurology Trainee Knowledge and Confidence: A Pilot Project (P8-7.005)	42
Digital Solutions: Exploring the Impact of Online Cognitive Rehabilitation on Quality of Life in Multiple Sclerosis Patients (P4-1.002)	41
Predictive Factors in Serious Non-traumatic Headache: A Caribbean Country Perspective (P3-12.008)	41
The COVID-19 Pandemic Significantly Affected Acute Ischemic Stroke Subtype, Patient Characteristics, and Outcomes (P8-11.018)	41
Acquired Hepatocerebral Degeneration: The Second Brain (HNS and CNS) (P8-5.029)	41
Real-world Outcomes with Directional Deep Brain Stimulation (DBS) Systems: Awake Versus Asleep Lead Placement (P9-5.011)	41
A Unique Presentation of Paraneoplastic-Variant Stiff Person Syndrome (P2-8.020)	41
Therapeutic Efficacy of Repetitive Nerve Stimulation (RNS) Therapy in Functional Movement Disorders: A Quantitative and Qualitative Analysis (N6.003)	41
Refining Neuro-ophthalmology Examination Proficiency in Neurology Residents Through Simulation-based Training (S14.005)	41
Distance Travelled by patient for appointment with the Movement disorder clinic at Kentucky Neuroscience Institute – how to solve the problem? (P10-11.005)	40
Primary Central Nervous System Histiocytic Sarcoma: A Systematic Review of Clinical Presentation, Radiologic Findings, Treatment Strategies, and Prognostic Outcomes (P9-6.009)	40
Chronic Kidney Disease and Risk of Intracerebral Hemorrhage: The Role of Hypertension as a Mediator (S34.004)	40
Valproic Acid is an Effective Anti-Emetic Treatment in Alexander Disease (P10-9.010)	40
Dual antiglutamatergic treatment in patients with status epilepticus: a case series (P9-1.008)	40
Impact of Serotonin Reuptake Inhibitors on Respiratory Patterns During Seizures in Adults with Epilepsy Undergoing SEEG Monitoring. (P4-9.004)	40
Investigating the Impact of Virtual Versus In-Person Small Group Discussion on Academic Performance in a First-Year Medical Neuroscience Course (S10.003)	40
Editors' Note: Association of Polysomnographic Sleep Parameters With Neuroimaging Biomarkers of Cerebrovascular Disease in Older Adults With Sleep Apnea	40
Synergistic effect of MTHFR polymorphisms in arterial ischemic stroke in young adult (P3-5.014)	40
Brain MRI Activity During the Year Before Pregnancy Can Predict Long-Term Clinical Worsening in Patients with Multiple Sclerosis (P11-3.018)	40
Predicting Outcomes and Prognosis in Adult Myelopathies in Adult Non-traumatic Myelopathies (P11-14.003)	40
Geographic Distribution of Amyotrophic Lateral Sclerosis (ALS) in the Chicagoland Area (P6-11.015)	39
Association Between DMD Genotype and Neurodevelopmental Concerns in Childhood-Onset Dystrophinopathy Using Population-Based Surveillance Data (P7-6.005)	39
Temporal Trends in Quality of Acute Stroke and Secondary Stroke Prevention Care in Patients with Pre-stroke Disability in the Safe Implementation of Treatment in Stroke (SITS) Registry (P1-5.002)	39
Structural Connectivity Changes in Brain Network After Spinal Cord Injury (P10-4.001)	39
COVID-19 Outcomes in Neurosarcoidosis (P9-5.012)	39
Association Between a Brain Care Score and Risk of Cerebrovascular Events in American Women (S11.004)	39
Anti-NMDA Encephalitis Co-positive with Aquaporin 4 Antibodies in a 4-year-old Female (P6-8.004)	38
Patient Use of Smartphone Videos to Capture Events in an Outpatient Epilepsy Practice (P7-1.009)	38
Three Month Functional Outcomes in Poor Grade Subarachnoid Hemorrhage Patients Undergoing Endovascular Treatment of Cerebral Vasospasm (P7-5.032)	38
Exposure-Response Modeling to Describe Change in Brain Amyloid Following Lecanemab Administration in Patients with Early Alzheimer’s Disease (P9-9.011)	38
Monoaminergic Network Abnormalities Explain Fatigue in Pediatric Multiple Sclerosis (S8.008)	38
Evaluating an Intergenerational Art and Storytelling Program with Older Adults and Medical Students (P5-9.016)	38
ChatGPT as Clinical Decision-Making Tool for Headache Screening (P4-12.009)	38
Acute Spinal Cord Infarction Following Cannabis Exposure (P7-5.015)	37
Bariatric Surgery as a Potential Trigger for Worsening HSP (P2-11.020)	37
Burkitt Lymphoma-associated GAD65 Encephalitis in a Child with New-onset, Refractory Seizures (P1-14.007)	37
Predictors of Post-Discharge Seizures in Aneurysmal Subarachnoid Hemorrhage Using EEG Data (S30.007)	37
Cervical Motion Alterations and Brain Functional Connectivity in Cervical Dystonia (P1-3.014)	37
Pathogenic MUYTH and Novel H3F3A Variants in Glioblastoma: A Case Report and Literature Review (P4-5.005)	37
Proximity to Green and Blue Spaces and Serious Psychological Distress in Urban-Dwelling Older Adults: Analysis of Washington State BRFSS data (P2-12.006)	37
Implementation of Depression Screening and Interventions Protocol in a Pediatric Neurology Residents’ Continuity Clinic: A Quality Improvement Project (P11-9.001)	36
The Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Single Center Experience (P9-14.018)	36
Sex Chromosomes and Gonad-dependent Sex Differences in Auditory Function in Mice (P7-10.001)	36
Investigation of Novel Variants in Familial Multiple Sclerosis Through Family-based Association Tests and Segregation Analyses (S17.007)	36
Airborne Trichloroethylene Exposure and Parkinson’s Disease Risk in Medicare Beneficiaries (S2.001)	36
Level of Blood Tau and pTau : A Non-Invasive Approach for the Diagnosis of Alzheimer’s Disease(AD). (P7-3.018)	36
Association of Disease Characteristics with Utilization of Behavioral Medicine in Patients with NMOSD and MOGAD (P13-5.016)	36
Spontaneous Spinal Epidural Hematoma Presented with Acute Hemiparesis: A Stroke Mimicker (P11-5.015)	36
Assessing Clinically Relevant Recovery of Visual Acuity Over Time in Patients with Leber Hereditary Optic Neuropathy Treated with Idebenone: Results from the LEROS Study (S40.001)	36
Comparison of Symptom Distribution and Severity in People with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Zambia (P9-1.013)	36
Evaluation of the Clinical Outcomes and Disease Burden in Advanced Parkinson’s Disease Patients: PROSPECT Study Preliminary Results (P10-11.009)	36
Reduced Aβ Amyloid Deposits Relate to Inflammation and Neuronal Survival in Multiple Sclerosis Cortex (S17.003)	36
Aqueously diffusible RNA-bound amyloid-β aggregates in Alzheimer disease brain (P1-6.004)	36
Message From the Editors to Our Reviewers	36
Efficacy of Adjunctive Cenobamate by Focal Seizure Subtypes: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study in a Multinational Asian Population (P8-9.006)	36
The Quix Test: Identifying Vestibular Dysfunction in the “Dizzy Patient” (P7-4.004)	36
Clonidine Withdrawal Resulting in Atypical Presentation of PRES (P2-8.007)	36
Optimal Care Access Disparities in Adult Non-English-speaking Patients with Drug-resistant Epilepsy (P10-1.005)	35
The Prevalence and Etiologies of Transverse Myelitis in Latin America: A Systematic Review (P4-8.011)	35
Association of Cytokine Proteins with Disease Activity in Neuromyelitis Optica Spectrum Disorder Participants Receiving Inebilizumab Treatment (S32.005)	35
Implementing and Assessing a Neuropalliative Communication Curriculum for Neurology Resident Physicians (P6-7.003)	35
Efficacy of Frexalimab on Physical and Psychological Impacts and Fatigue in Relapsing Multiple Sclerosis: Findings from MSIS-29v2 and PROMIS-Fatigue-MS-8a Assessments in a Phase 2 Trial (P10-6.001)	35
The relationship between gender, peer victimization, mental health, and frequent headaches in adolescents: A Canadian population-based observational study (P14-12.002)	35
A Case of Infant-type Hemispheric Glioma with NTRK1 fusion (P9-13.003)	35
Oral health-related quality of life in multiple sclerosis and neuromyelitis optica spectrum disorder patients from Argentina (P5-3.007)	35
Associations Between Neuropsychiatric Symptom Burden, Change in Cognitive Status and Survival in Autopsy-confirmed Cohorts of Lewy Body Disease and Alzheimer’s Disease (P1-5.028)	35